A new pharmaceutical concoction created by Swiss pharmaceutical giant, Ludacrix, is promising great results for domain investors.
Engineered to provide a sustainable boost of mental and physical energy, Ludacrix Boost comes both in liquid and chewable forms.
“We’ve taken a lot of data into consideration, after working with a sample of 24 domainers for two years,” said company spokesperson, Tia Vardoska.
“Half of them were given a placebo while the other half of the patients were prescribed various dosages of Ludacrix Boost. The end results are amazing,” she added.
In 90% of the cases, domainers that took the recommended dosage of Ludacrix Boost witnessed an increase of 150% in both physical and mental lucidity and were able to register, develop and sell domains faster, and at higher prices.
While Ludacrix is still fine-tuning its claims in order to pass the strict rules of the American FDA, domainers in the US that are eager to test the new “wonder drug” can order it directly from the Swiss corporation, at LudacrixPharmaceuticals.ch
